Remicade 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9DJ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,052
Award facts
- Contract value 100% obligated
- $23,051.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on November 26, 2025, valued at $23,051.81 for the supply of Remicade 100 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 28, 2025, and carries no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Remicade is a biologic immunosuppressant medication commonly used in military and veteran healthcare systems to treat autoimmune inflammatory conditions. AmerisourceBergen's substantial DLA contract portfolio reflects the company's established capability to meet federal medical procurement requirements through open competition, supporting critical healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical contract demonstrates the company's role as a key vendor for pharmaceutical commodities essential to military readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9DJ6?
SPE2DR26F9DJ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F9DJ6 worth?
The government has obligated $23,052 on SPE2DR26F9DJ6.
Is contract SPE2DR26F9DJ6 an order under another contract?
Yes. SPE2DR26F9DJ6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DJ6 competed?
The extent of competition for SPE2DR26F9DJ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award